This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Duke University. Active years: 2021-2022.
Company Filing History:
Years Active: 2021-2022
Title: Innovations by Robin Bachelder
Introduction
Robin Bachelder is an accomplished inventor based in Durham, NC (US). He has made significant contributions to the field of biomedical research, particularly in the development of innovative treatments for fibrotic conditions. With a total of 2 patents to his name, Bachelder's work focuses on addressing critical health issues related to fibrosis.
Latest Patents
Bachelder's latest patents include groundbreaking inventions aimed at improving the detection and treatment of pathological conditions. One of his notable patents is for "Anti-pro-N-cadherin antibodies and methods of treating pathological fibrotic conditions and tumor cells." This humanized antibody targets a mislocated form of N-cadherin, which is found in fibrotic conditions affecting various organs, including the heart, lung, liver, kidney, and skin. Importantly, this antibody selectively eliminates cells expressing the protein extracellularly, leaving normal cells unharmed. Another significant patent is for "Compositions and methods for detecting and treating pathological fibroblast cells." This invention provides compositions, kits, and methods for assessing the presence of pathological fibroblasts in biological samples, as well as methods for treating fibrosis and related conditions.
Career Highlights
Robin Bachelder is affiliated with Duke University, where he conducts his research and development work. His role at this prestigious institution allows him to collaborate with leading experts in the field and contribute to advancements in medical science.
Collaborations
Bachelder has worked alongside notable colleagues, including Salvatore Pizzo and Paul Ferrell. Their collaborative efforts have further enhanced the impact of his research and innovations.
Conclusion
Robin Bachelder's contributions to the field of biomedical research through his patents and collaborations highlight his commitment to improving health outcomes for patients with fibrotic conditions. His innovative approaches continue to pave the way for advancements in medical treatments.